Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma

Prostate

Volumn 28, Issue 5, 1996, Pages 275-281

  Ittmann, Michael M ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

BRCA 1 gene; microsatellite markers; NF 1 gene; tumor suppressor genes

Indexed keywords

TUMOR MARKER;

ARTICLE; CHROMOSOME 10; CHROMOSOME 17; CHROMOSOME LOSS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; BLOTTING, SOUTHERN; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 10; CHROMOSOMES, HUMAN, PAIR 17; DNA PROBES; DNA, NEOPLASM; GENES, TUMOR SUPPRESSOR; HETEROZYGOTE; HUMANS; MALE; MICROSATELLITE REPEATS; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS;

EID: 0029873325     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199605)28:5<275::AID-PROS1>3.0.CO;2-B     Document Type: Article

References (38)

1. Kern S, Hamilton S, Vogelstein B: Clinical implications of colorectal tumor mutations. In Samuel Broder (ed.): "Molecular Foundations of Oncology." Baltimore: Williams and Wilkins, 1991, pp 381-386.
2. Carbone D, Minna, J: Molecular biology of lung cancer. In Samuel Broder (ed.): "Molecular Foundations of Oncology." Baltimore: William and Wilkens, 1991, pp 339-366.
3. Thompson T: Growth factors and oncogenes in prostate cancer. Cancer Cells 2:345-354, 1990.
4. Bergerheim U, Kunimi K, Collins V, Ekman, P: Deletion mapping of chromosome 8,10,16 in human prostatic carcinoma. Genes Chromosom Cancer 3:215-220, 1991.
5. Bergerheim U, Collins V, Ekman P, Kunimi K: Recessive genetic mechanisms in the oncogenesis of prostatic carcinoma. Scand J Urol Nephrol [Suppl] 138:93-96, 1991.
6. Kunimi K, Bergerheim U, Larsson I-L, Ekman P, Collins V: Allelotyping of human prostatic adenocarcinoma. Genomics 11:530-536, 1991.
7. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 87:8751-8755, 1990.
8. Gao X, Honn K, Grignon D, Sakr W, Chen Y: Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res 53:2723-2727, 1993.
9. Bova GS, Carter BS, Bussemakers MJG, Emi M, Fujiwara Y, Kyprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, Issacs WB: Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53:3869-3873, 1993.
10. Phillips S, Morton D, Lee S, Wallace D, Neoptolemus J: Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and chromosomes 10p, 10q and 16q in human prostate cancer. Br J Urol 73:390-395, 1994.
11. Ittmann M, Wieczorek R, Heller P, Dave A, Provet J, Krolewski J: Alterations in the p53 and MDM-2 genes are infrequent in clinically localized, Stage B prostate adenocarcinomas. Am J Pathol 145:287-293, 1994.
12. Bookstein R, MacGrogan D, Hilsenbeck SG, Sharkey F, Allred DC: p53 is mutated in a subset of advancedstage prostate cancers. Cancer Res 53:3369-3373, 1993.
13. Mellon K, Thompson S, Charlton RG, Marsh C, Robinson M, Lane DP, Harris AL, Wilson Home CH, Neal DE: p53, c-cerb-2 and the epidermal growth factor receptor in the benign and malignant prostate. J Urol 147:496-499, 1992.
14. Soini Y, Paakko P, Nuorva K, Kamel D, Lane DP, Vahakangas K: Comparative analysis of p53 protein immunoreactivity in prostatic, lung and breast carcinomas. Virchows Arch [A] 421:223-228, 1992.
15. Visakorpi T, Kallioniemi I-P, Heikkinen A, Koivula T, Isola J: A small subgroup of aggressive highly proliferative prostatic carcinomas defined by p53 accumulation. J Natl Cancer Inst 84:883-887, 1992.
16. Frankel R, Bayona W, Koslow M, Newcomb EW: p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res 52:1427-1433, 1992.
17. Andersen LB, Tarle SA, Marchuk DA, Legius E, Collins FS: A compound nucleotide repeat in the neurofibromatosis (NF1) gene. Hum Mol Genet 2:1083, 1993.
18. Seizinger B: NF1: a prevalent cause of tumorigenesis in human cancers? Nature Genetics 3:97-99, 1993.
19. Hall J, Lee M, Newman B, Morrow J, Anderson L, Huey B, King M: Linkage of early-onset familial breast cancer of chromosome 17q21. Science 250:1684-1689, 1990.
20. Futreal P, Soderkvist P, Marks J, Iglehart J, Cochran C, Barrett J, Wiseman R: Detection of frequent allelic loss on proximal 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res 52: 2624-2627, 1992.
21. Tulinius H, Egilsson V, Olafsdottir GH, Sigvaldason H: Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. Brit Med J 305:855-857, 1992.
22. Tomfohrde J, Wood S, Schertzer M, Wagner M, Wells D, Parrish J, Sadler L, Blanton S, Daiger S, Wang Z, Wilkie D, Weber J: Human chromosome 8 linkage map based on short tandem repeats polymorphisms: effect of genotyping errors. Genomics 14:144-152, 1992.
23. Genethon Microsatellite Map Catalogue 1992. Evry, France: Human Genome Research Centre, 1992.
24. Jones MH, Nakamura Y: Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism. Genes, Chromosomes & Cancer 5:89-90, 1992.
25. Weber J, Kwitek A, May P, Wallace M, Collins F, Ledbetter D: Dinucleotide repeat polymorphisms at the D17S250 and D17S261 loci. Nucl Acid Res 18:4640, 1990.
26. Gruis NA, Abeln ECA, Bardoel AFJ, Devilee P, Frants RR, Cornelisse CJ: PCR-based microsatellite polymorphisms in the detection of loss of heterozygosity in fresh and archival tumor tissue. Br J Cancer 68:308-313, 1993.
27. Neri A, Chang C, Lombardi L, Salina M, Corradini P, Maiolao A, Chaganti R, Dalla-Favera R: B Cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-KB p50. Cell 67:1075-1087, 1991.
28. Mansour S, Martin G: Four classes of mRNA are expressed from the mouse int-2 gene, a member of the FGF gene family. EMBO J 7:2035-2041, 1988.
29. Fults D, Pedone C, Thomas G, White R: Allelotype of human malignant astrocytoma. Cancer Res 50:5784-5789, 1990.
30. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM: p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human strocytoma progression. Cancer Res 52:674-679, 1992.
31. 11 dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens. Am J Pathol 141:777-782, 1992.
32. Karlbom A, James C, Boethius J, Cavenee W, Collins V, Nordenskjold M, Larsson C: Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10. Hum Genet 92:169-174, 1993.
33. Ye Z, Wu JK, Darras BT: Loss of heterozygosity for alleles on chromosome 10 in human brain tumors. Neurol Res 15:59-63, 1993.
34. Louis D, Mani-Paz R, Correa K, Gusella J, Deimling A: Molecular genetics of pediatric brain stem gliomas. Application of PCR techniques to small and archival brain tumor specimens. J Neuropathol Exp Neurol 52:507-515, 1993.
35. Monta R, Saito S, Ishikawa J, Ogawa O, Yoshida O, Yamakawa K, Nakamura Y: Common regions of deletion on chromosomes 5q, 6q, and 10q in renal cell carcinoma. Cancer Res 51:5817-5820, 1991.
36. Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishikawa T, Nakagama H, Harada H, Yagura M, Matsubara K, Nakamura Y: Alleotyping study of primary hepatocellular carcinoma. Cancer Res 51:89-93, 1991.
37. Rempel S, Schwechheimer K, Davis R, Cavenee W, Rosenblum M: Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res 53:2386-2392, 1993.
38. Brewster S, Browne S, Brown K: Somatic allelic loss at the DCC, APC, nm23-H1, and p53 tumor suppressor gene loci in human prostate carcinoma. J Urol 151: 1073-1077, 1994.